Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $11.41 billion. The enterprise value is $10.54 billion.
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026, before market open.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MDGL has 22.71 million shares outstanding. The number of shares has increased by 6.98% in one year.
| Current Share Class | 22.71M |
| Shares Outstanding | 22.71M |
| Shares Change (YoY) | +6.98% |
| Shares Change (QoQ) | +1.24% |
| Owned by Insiders (%) | 8.56% |
| Owned by Institutions (%) | 69.94% |
| Float | 12.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.12 |
| Forward PS | 8.17 |
| PB Ratio | 18.32 |
| P/TBV Ratio | 18.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.55.
| Current Ratio | 3.44 |
| Quick Ratio | 3.12 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.56 |
Financial Efficiency
Return on equity (ROE) is -41.22% and return on invested capital (ROIC) is -20.57%.
| Return on Equity (ROE) | -41.22% |
| Return on Assets (ROA) | -15.78% |
| Return on Invested Capital (ROIC) | -20.57% |
| Return on Capital Employed (ROCE) | -31.67% |
| Revenue Per Employee | $1.40M |
| Profits Per Employee | -$547,585 |
| Employee Count | 528 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 0.90 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.66% in the last 52 weeks. The beta is -1.01, so MDGL's price volatility has been lower than the market average.
| Beta (5Y) | -1.01 |
| 52-Week Price Change | +71.66% |
| 50-Day Moving Average | 555.93 |
| 200-Day Moving Average | 404.70 |
| Relative Strength Index (RSI) | 36.24 |
| Average Volume (20 Days) | 297,917 |
Short Selling Information
The latest short interest is 3.71 million, so 16.34% of the outstanding shares have been sold short.
| Short Interest | 3.71M |
| Short Previous Month | 3.72M |
| Short % of Shares Out | 16.34% |
| Short % of Float | 30.82% |
| Short Ratio (days to cover) | 13.37 |
Income Statement
In the last 12 months, MDGL had revenue of $740.64 million and -$289.13 million in losses. Loss per share was -$13.04.
| Revenue | 740.64M |
| Gross Profit | 705.50M |
| Operating Income | -307.48M |
| Pretax Income | -289.13M |
| Net Income | -289.13M |
| EBITDA | -306.01M |
| EBIT | -307.48M |
| Loss Per Share | -$13.04 |
Full Income StatementBalance Sheet
The company has $1.11 billion in cash and $346.40 million in debt, with a net cash position of $763.35 million or $33.61 per share.
| Cash & Cash Equivalents | 1.11B |
| Total Debt | 346.40M |
| Net Cash | 763.35M |
| Net Cash Per Share | $33.61 |
| Equity (Book Value) | 625.73M |
| Book Value Per Share | 27.56 |
| Working Capital | 955.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$160.58 million and capital expenditures -$1.05 million, giving a free cash flow of -$161.63 million.
| Operating Cash Flow | -160.58M |
| Capital Expenditures | -1.05M |
| Free Cash Flow | -161.63M |
| FCF Per Share | -$7.12 |
Full Cash Flow StatementMargins
Gross margin is 95.25%, with operating and profit margins of -41.52% and -39.04%.
| Gross Margin | 95.25% |
| Operating Margin | -41.52% |
| Pretax Margin | -39.04% |
| Profit Margin | -39.04% |
| EBITDA Margin | -41.32% |
| EBIT Margin | -41.52% |
| FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.98% |
| Shareholder Yield | -6.98% |
| Earnings Yield | -2.56% |
| FCF Yield | -1.43% |
Dividend DetailsAnalyst Forecast
The average price target for MDGL is $597.54, which is 18.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $597.54 |
| Price Target Difference | 18.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 73.57% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 4.3 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.3 |
| Piotroski F-Score | 2 |
